Sponsored

How well do you know your patients?

With rare disease patient adherence at only 58-65 percent, many manufacturers traditionally
research and refine their market access, pricing and distribution strategies. Equally important - new insights from clinical care experts and patient advocacy organizations call attention to the unknown and unmet needs of the patient journey.

In its new white paper, Precision Medicine Meets Precision Patient Support, Dohmen Life Science Services, showcases a more comprehensive approach to patient understanding and how it shapes a fully integrated exclusive distribution model, featuring wrap-around patient services to drive better outcomes. Click below to read more.

Access the white paper here 


Nicole Boice, Global Genes CEO: “A better understanding, ideally, would facilitate a true partnership among patient communities and the industry. It would inform the development of support programs that would have a meaningful impact on patients’ and families’ lives. Any time a company truly understands the patient experience and journey, it is a win-win for all involved.”

Linda Newberry-Ferguson, DLSS Senior Vice President of Clinical Navigation. “You’ve got to see the patient as an individual, not a category or community. Patients with the same disease on the same therapy will often have different needs and reasons for nonadherence.”

...............................................................................................................................................................................................

Dohmen Life Science Services is the leading business process outsourcing partner to pharmaceutical and biologics companies. With the broadest suite of services in the industry, DLSS has helped more than 600 companies strengthen and simplify relationships with their customers, grow their business and realize their vision. Whether it’s navigating regulatory requirements during clinical trial, launching new products, managing daily operations or providing patient-centric care in support of products for rare diseases, DLSS helps our clients advance with speed, scale and certainty. A member of the Dohmen family of companies, visit www.dlss.com to learn more.

This article was created in collaboration with the sponsoring company and our sales and marketing team. The editorial team does not contribute.